Apoptosis and microRNA aberrations in cancer

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 8, 2012, Pages 739-746

  Li, Chun ^a   Hashimi, Saeed M ^a   Good, David A ^a   Cao, Siyu ^a   Duan, Wei ^b   Plummer, Prue N ^a   Mellick, Albert S ^a   Wei, Ming Q ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

Apoptosis; MicroRNA; Oncomir

Indexed keywords

CURCUMIN; GLUCOCORTICOID; MICRORNA; MICRORNA 101; MICRORNA 10B; MICRORNA 1204; MICRORNA 143; MICRORNA 145; MICRORNA 15; MICRORNA 150; MICRORNA 155; MICRORNA 16; MICRORNA 17; MICRORNA 203; MICRORNA 205; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 23A; MICRORNA 29B; MICRORNA 31; MICRORNA 34; MICRORNA 92; NICOTINAMIDE; ONCOMIR; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER DIAGNOSIS; CANCER PROGNOSIS; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL MATURATION; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; NONHUMAN; REVIEW; UPREGULATION;

EID: 84864312441     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2012.05700.x     Document Type: Review

References (130)

1. Kepp O, Tesniere A, Schlemmer F et al. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 2009; 14: 364-75.
2. Henson PM. Dampening inflammation. Nat. Immunol. 2005; 6: 1179-81.
3. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002; 2: 183-92.
4. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999; 13: 1899-911.
5. Martinou JC, Green DR. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell Biol. 2001; 2: 63-7.
6. Brooks C, Wei Q, Feng L et al. Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. Proc. Natl Acad. Sci. USA 2007; 104: 11649-54.
7. Klein S, McCormick F, Levitzki A. Killing time for cancer cells. Nat. Rev. Cancer 2005; 5: 573-80.
8. Berube C, Boucher LM, Ma W et al. Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc. Natl Acad. Sci. USA 2005; 102: 14314-20.
9. Lujambio A, Calin GA, Villanueva A et al. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl Acad. Sci. USA 2008; 105: 13556-61.
10. Saito Y, Liang G, Egger G et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9: 435-43.
11. Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 2006; 13: 1097-101.
12. Lee Y, Ahn C, Han J et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 415-9.
13. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 2004; 18: 3016-27.
14. Han J, Lee Y, Yeom KH et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006; 125: 887-901.
15. Diederichs S, Haber DA. Sequence variations of microRNAs in human cancer: Alterations in predicted secondary structure do not affect processing. Cancer Res. 2006; 66: 6097-104.
16. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003; 17: 3011-6.
17. MacRae IJ, Ma E, Zhou M, Robinson CV, Doudna JA. In vitro reconstitution of the human RISC-loading complex. Proc. Natl Acad. Sci. USA 2008; 105: 512-7.
18. Diederichs S, Haber DA. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 2007; 131: 1097-108.
19. Miyoshi K, Tsukumo H, Nagami T, Siomi H, Siomi MC. Slicer function of Drosophila Argonautes and its involvement in RISC formation. Genes Dev. 2005; 19: 2837-48.
20. Haase AD, Jaskiewicz L, Zhang H et al. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 2005; 6: 961-7.
21. Lee Y, Hur I, Park SY, Kim YK, Suh MR, Kim VN. The role of PACT in the RNA silencing pathway. EMBO J. 2006; 25: 522-32.
22. Huntzinger E, Izaurralde E. Gene silencing by microRNAs. Contributions of translational repression and mRNA decay. Nat. Rev. Genet. 2011; 12: 99-110.
23. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-33.
24. Sun G, Yan J, Noltner K et al. SNPs in human miRNA genes affect biogenesis and function. RNA 2009; 15: 1640-51.
25. Liu Z, Wei S, Ma H et al. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2011; 32: 1668-74.
26. He L, Thomson JM, Hemann MT et al. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-33.
27. Thapa DR, Li X, Jamieson BD, Martinez-Maza O. Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas. PLoS One 2011; 6: e20781.
28. Kanzaki H, Ito S, Hanafusa H et al. Identification of direct targets for the miR-17-92 cluster by proteomic analysis. Proteomics 2011; 11: 3531-9.
29. Tsuchida A, Ohno S, Wu W et al. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci. 2011; 102: 2264-71.
30. Kim K, Chadalapaka G, Lee SO et al. Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 2011a; 31: 1034-44.
31. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839-43.
32. Molitoris JK, McColl KS, Distelhorst CW Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17-92 contributes to the induction of Bim and initiation of apoptosis. Mol. Endocrinol. 2011; 25: 409-20.
33. Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell. Biol. 2006; 26: 8191-201.
34. Yu Z, Wang C, Wang M et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol. 2008; 182: 509-17.
35. He L, He X, Lim LP et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-4.
36. Tarasov V, Jung P, Verdoodt B et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: MiR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007; 6: 1586-93.
37. Raver-Shapira N, Marciano E, Meiri E et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 2007; 26: 731-43.
38. Chang TC, Wentzel EA, Kent OA et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 2007; 26: 745-52.
39. Yang L, Belaguli N, Berger DH. MicroRNA and colorectal cancer. World J. Surg. 2009; 33: 638-46.
40. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA 2007; 104: 15.
41. Ogura M, Agata Y, Watanabe K et al. RNA chip: Quality assessment of RNA by microchannel linear gel electrophoresis in injection-molded plastic chips. Clin. Chem. 1998; 44: 2249-55.
42. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005; 65: 6029-33.
43. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 2007; 282: 14328-36.
44. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-58.
45. Wang Y, Xu Y, Wang H et al. Arsenic induces mitochondria-dependent apoptosis by reactive oxygen species generation rather than glutathione depletion in Chang human hepatocytes. Arch. Toxicol. 2009; 83: 899-908.
46. Jansen AP, Camalier CE, Colburn NH. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res. 2005; 65: 6034-41.
47. Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, Allgayer H. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 2007; 26: 4550-62.
48. Allgayer H. Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit. Rev. Oncol. Hematol. 2009; 73: 185-91.
49. Kim K, Lee HC, Park JL et al. Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 2011b; 6: 740-51.
50. Eis PS, Tam W, Sun L et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl Acad. Sci. USA 2005; 102: 3627-32.
51. Clurman BE, Hayward WS. Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: Evidence for stage-specific events. Mol. Cell. Biol. 1989; 9: 2657-64.
52. Tam W, Ben-Yehuda D, Hayward WS. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol. Cell. Biol. 1997; 17: 1490-502.
53. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosom. Cancer 2004; 39: 167-9.
54. Costinean S, Zanesi N, Pekarsky Y et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E (mu)-miR155 transgenic mice. Proc. Natl Acad. Sci. USA 2006; 103: 7024-9.
55. Gironella M, Seux M, Xie MJ et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl Acad. Sci. USA 2007; 104: 16170-5.
56. Szafranska AE, Davison TS, John J et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007; 26: 4442-52.
57. Yu Y, Sun G, Liu G et al. Effects of Mycoplasma pneumoniae infection on sphingolipid metabolism in human lung carcinoma A549 cells. Microb. Pathog. 2009; 46: 63-72.
58. Wang HQ, Yu XD, Liu ZH et al. Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. J. Pathol. 2011a; 225: 232-42.
59. Lu C, Huang X, Zhang X et al. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 2011; 117: 4293-303.
60. Yanaihara N, Caplen N, Bowman E et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-98.
61. Jamieson NB, Morran DC, Morton JP et al. MicroRNA molecular profiles associated with diagnosis, clinicopathological criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin. Cancer Res. 2011; 18: 534-45.
62. Tsuda N, Kawano K, Efferson CL, Ioannides CG. Synthetic microRNA and double-stranded RNA targeting the 3′-untranslated region of HER-2/neu mRNA inhibit HER-2 protein expression in ovarian cancer cells. Int. J. Oncol. 2005; 27: 1299-306.
63. Sakurai F, Katayama K, Mizuguchi H. MicroRNA-regulated transgene expression systems for gene therapy and virotherapy. Front. Biosci. 2011; 17: 2389-401.
64. Kim JK, Choi KJ, Lee M, Jo MH, Kim S. Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle. Biomaterials 2012; 33: 207-17.
65. Hwang do W, Ko HY, Lee JH et al. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J. Nucl. Med. 2010; 51: 98-105.
66. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB. MicroRNA regulation of a cancer network. Consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc. Natl Acad. Sci. USA 2008; 105: 19678-83.
67. Taguchi A, Yanagisawa K, Tanaka M et al. Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res. 2008; 68: 5540-5.
68. Dews M, Homayouni A, Yu D et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 2006; 38: 1060-5.
69. Ernst A, Campos B, Meier J et al. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene 2010; 29: 3411-22.
70. Raponi M, Dossey L, Jatkoe T et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 2009; 69: 5776-83.
71. Mu P, Han YC, Betel D et al. Genetic dissection of the miR-17-92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 2009; 23: 2806-11.
72. Monzo M, Navarro A, Bandres E et al. Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res. 2008; 18: 823-33.
73. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene 2006; 26: 2799-803.
74. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo Y-Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008; 18: 350-9.
75. Yao Q, Cao S, Li C, Mengesha A, Kong B, Wei M. MicroRNA-21 regulates TGF-beta-induced myofibroblast differentiation by targeting PDCD4 in tumour-stroma interaction. Int. J. Cancer 2010; 128: 1783-92.
76. Kong W, Yang H, He L et al. MicroRNA-155 is regulated by TGF{beta}/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 2008; 28: 6773-84.
77. Jiang S, Zhang HW, Lu MH et al. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res. 2010; 70: 3119-27.
78. Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc. Natl Acad. Sci. USA 2010; 107: 3111-6.
79. O'Connell RM, Rao DS, Chaudhuri AA et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 2008; 205: 585-94.
80. Fu X, Wang Q, Chen J et al. Clinical significance of miR-221 and its inverse correlation with p27 (Kip1) in hepatocellular carcinoma. Mol. Biol. Rep. 2011; 38: 3029-35.
81. Di Leva G, Gasparini P, Piovan C et al. MicroRNA. cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J. Natl Cancer Inst. 2010; 102: 706-21.
82. Zhang CZ, Han L, Zhang AL et al. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 2010a; 10: 367.
83. Garofalo M, Di Leva G, Romano G et al. miR-221 & 222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 2009; 16: 498-509.
84. Das SK, Sokhi UK, Bhutia SK et al. Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells. Proc. Natl Acad. Sci. USA 2010; 107: 11948-53.
85. Merkel O, Asslaber D, Pinon JD, Egle A, Greil R. Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia. Cell Cycle 2010; 9: 2764-8.
86. Christoffersen NR, Shalgi R, Frankel LB et al. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ. 2010; 17: 236-45.
87. Antonini D, Russo MT, De Rosa L, Gorrese M, Del Vecchio L, Missero C. Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. J. Invest. Dermatol. 2010; 130: 1249-57.
88. Gallardo E, Navarro A, Vinolas N et al. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 2009; 30: 1903-9.
89. Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol. Ther. 2008; 7: 1288-96.
90. Ji Q, Hao X, Zhang M et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS ONE 2009; 4: e6816.
91. Wang BD, Kline CL, Pastor DM et al. Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network. Mol. Cancer 2010; 9: 98.
92. Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer. Discovery, function and future perspectives. Cell Death Differ. 2010; 17: 215-20.
93. Xia L, Zhang D, Du R et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 2008; 123: 372-9.
94. Cimmino A, Calin GA, Fabbri M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA 2005; 102: 13944-9.
95. Bonci D, Coppola V, Musumeci M et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 2008; 14: 1271-7.
96. Peng Y, Laser J, Shi G et al. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol. Cancer Res. 2008; 6: 663-73.
97. Wong TS, Man OY, Tsang CM et al. MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. J. Cancer Res. Clin. Oncol. 2011; 137: 415-22.
98. He XY, Chen JX, Zhang Z, Li CL, Peng QL, Peng HM. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice. J. Cancer Res. Clin. Oncol. 2010; 136: 1023-8.
99. Tsang WP, Kwok TT. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 2008; 13: 1215-22.
100. Zhao Y, Deng C, Wang J et al. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res. Treat. 2011; 127: 69-80.
101. Lu L, Katsaros D, Shaverdashvili K et al. Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. Eur. J. Cancer 2009; 45: 2212-8.
102. Trang P, Medina PP, Wiggins JF et al. Regression of murine lung tumors by the let-7 microRNA. Oncogene 2010; 29: 1580-7.
103. Akao Y, Nakagawa Y, Naoe T. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull. 2006; 29: 903-6.
104. O'Hara AJ, Wang L, Dezube BJ, Harrington WJ Jr, Damania B, Dittmer DP. Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood 2009; 113: 5938-41.
105. Clape C, Fritz V, Henriquet C et al. miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS ONE 2009; 4: e7542.
106. Ng EK, Tsang WP, Ng SS et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br. J. Cancer 2009; 101: 699-706.
107. Kulda V, Pesta M, Topolcan O et al. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet. Cytogenet. 2010; 200: 154-60.
108. Akao Y, Nakagawa Y, Iio A, Naoe T. Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leuk. Res. 2009; 33: 1530-8.
109. Barsotti A, Beckerman R, Laptenko O, Huppi K, Caplen NJ, Prives C. P53-dependent induction of PVT1 and miR-1204. J. Biol. Chem. 2012; 287: 2509-19.
110. Le MT, Shyh-Chang N, Khaw SL et al. Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs. PLoS Genet. 2011; 7: e1002242.
111. Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, White RW. miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 2011; 71: 538-49.
112. Watanabe A, Tagawa H, Yamashita J et al. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011; 25: 1324-34.
113. Cazanave SC, Mott JL, Elmi NA et al. A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA. J. Lipid Res. 2011; 52: 1517-25.
114. Gabriely G, Yi M, Narayan RS et al. Human glioma growth is controlled by microRNA-10b. Cancer Res. 2011; 71: 3563-72.
115. Sharma AD, Narain N, Handel EM et al. MicroRNA-221 regulates FAS-induced fulminant liver failure. Hepatology 2011; 53: 1651-61.
116. Zhang C, Zhang J, Zhang A et al. PUMA is a novel target of miR-221/222 in human epithelial cancers. Int. J. Oncol. 2010b; 37: 1621-6.
117. Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA. Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev. 2011; 25: 646-59.
118. Zhang H, Zuo Z, Lu X, Wang L, Wang H, Zhu Z. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol. Rep. 2012; 27: 594-8.
119. Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. J. Thorac. Oncol. 2011a; 6: 671-8.
120. Li J, Chen Y, Zhao J, Kong F, Zhang Y. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett. 2011; 304: 52-9.
121. 3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. Cancer Res. 2011; 71: 6230-9.
122. Zhang YK, Wang H, Leng Y et al. Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1. Biochem. Biophys. Res. Commun. 2011b; 414: 233-9.
123. Borralho PM, Simoes AE, Gomes SE et al. miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. PLoS ONE 2011; 6: e23787.
124. Sayed D, He M, Hong C et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J. Biol. Chem. 2010; 285: 20281-90.
125. Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J. Biol. Chem. 2011; 286: 16606-14.
126. He B, Xiao J, Ren AJ et al. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J. Biomed. Sci. 2011; 18: 22.
127. Siegel C, Li J, Liu F, Benashski SE, McCullough LD. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc. Natl Acad. Sci. USA 2011; 108: 11662-7.
128. Fang J, Song XW, Tian J et al. Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis: an international journal on programmed cell death 2012; 17: 410-23.
129. Chen X, Gong J, Zeng H et al. MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res. 2010; 70: 2728-38.
130. Sharbati J, Lewin A, Kutz-Lohroff B, Kamal E, Einspanier R, Sharbati S. Integrated microRNA-mRNA-analysis of human monocyte derived macrophages upon Mycobacterium avium subsp. hominissuis infection. PLoS ONE 2011; 6: e20258.